logo_black.png
EXMceuticals Inc. Announces Transformational Merger with Global Cannabinoids and Launches Concurrent Equity Financing
03 mars 2021 10h26 HE | EXMceuticals Inc.
NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, March 03, 2021 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the "Company" or...
logo_black.png
EXMceuticals Inc. becomes member of the Portuguese Association of the Pharmaceutical Industry (APIFARMA).
29 sept. 2020 09h00 HE | EXMceuticals Inc.
VANCOUVER, British Columbia, Sept. 29, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (OTCQB:EXM…, (the "Company" or "EXM"), an emerging bio-sciences company specializing in the...
exm_logo.png
EXMceuticals Inc. Announces Receipt of Landmark COVID-19 Research Grant and Acceleration of Portuguese Activities
08 sept. 2020 09h00 HE | EXMceuticals Inc.
VANCOUVER, British Columbia, Sept. 08, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM"), an emerging bio-sciences company specializing in the production...
exm_logo.png
EXMceuticals Inc. Announces Advancement of R&D Operations in Portugal and Efforts to Fight COVID-19 Pandemic
25 août 2020 08h00 HE | EXMceuticals Inc.
VANCOUVER, British Columbia, Aug. 25, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM"), an emerging bio-science company specializing in the production of...
CB2 Insights.jpg
CB2 Insights to Host Q1 2020 Earnings Call on July 15, 2020
08 juil. 2020 16h45 HE | CB2 Insights
TORONTO, July 08, 2020 (GLOBE NEWSWIRE) -- CB2 Insights Inc. (“CB2” or the “Company”) (CSE: CBII; OTCQB: CBIIF), will be hosting its Q1 2020 earnings call on Wednesday, July 15, 2020 at 9:00 a.m....
DM 413 x 176.png
Datametrex Provides Update on Canntop AI Pilot Program with Empower
19 mars 2019 07h00 HE | Datametrex AI Limited
TORONTO, March 19, 2019 (GLOBE NEWSWIRE) -- Datametrex AI Limited (TSXV:DM) (the “Company” or “Datametrex”) is pleased to provide update on its pilot program with EMPOWER CLINICS INC. (CSE: EPW)...